To investigate the impact of somatic mutations in homologous recombination (HR) genes on the chemotherapeutic response and survival of patients with epithelial ovarian cancer (EOC).

Paclitaxel is necessary for improved survival in epithelial ovarian cancers with homologous recombination gene mutations

BENEDETTO, Chiara;CANUTO, Emilie Marion;
2016-01-01

Abstract

To investigate the impact of somatic mutations in homologous recombination (HR) genes on the chemotherapeutic response and survival of patients with epithelial ovarian cancer (EOC).
2016
7
30
48577
48585
clinical molecular genetics; homologous recombination; massively parallel sequencing; ovarian cancer; paclitaxel
Jean, Stephanie; Li, Jiaqi; Katsaros, Dionyssios; Wubbenhorst, Bradley; Maxwell, Kara N; Fishbein, Lauren; Mclane, Michael W; Benedetto, Chiara; Canut...espandi
File in questo prodotto:
File Dimensione Formato  
Paclitaxel is necessary for improved survival in epithelial ovarian cancers ....pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 1.53 MB
Formato Adobe PDF
1.53 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1594716
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 3
social impact